Inventor
Wolfgang Staehle
Inventor
Ingelheim am Rhein, DE
Overview
Patents· 33 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes22%
Y02ATechnologies for adaptation to climate change3%
C07CAcyclic or carbocyclic compounds2%
A61NElectrotherapy1%
C04BLime, magnesia1%
PatentTitleYear
10,118,9193-substituted cyclopentylamine derivatives20189,809,552'Piperazine derivatives as FASN inhibitors'20179,790,216'3-substituted cyclopentylamine derivatives'20179,732,032'3-aminocyclopentane carboxamide derivatives'20179,718,785'1,3-Disubstituted cyclopentane derivatives'20179,670,142'1,3-diaminocyclopentane carboxamide derivatives'20179,527,850'Benzyl piperidine compounds as lysophosphatidic acid (LPA) receptor antagonist'20169,452,997'Piperidine and piperazine derivatives as autotaxin inhibitors'20169,416,133'Hydropyrrolopyrrole derivatives for use as fatty acid synthase inhibitors'20169,283,225'Pyrido-pyrimidine derivatives'20169,249,114'Thiazole derivatives'20169,067,938'Pyrazolopyridinone derivatives as LPA receptor antagonists'20159,029,387'Benzonaphthyridinamines as autotaxin inhibitors'20158,912,202'N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists'20148,859,775'Pyrazolopyridinone derivatives as LPA receptor antagonists'20148,859,581'Azaheterocyclic compounds as kinase inhibitors'20148,841,324'Heterocyclic compounds as autotaxin inhibitors'20148,822,476'Piperidine and piperazine derivatives as autotaxin inhibitors'20148,557,824'Thiazole derivatives'20138,552,001'Sulfoxide derivatives for the treatment of tumors'20138,530,650'2, 5-diamino-substituted pyrido [4, 3-D] pyrimidines as autotaxin inhibitors against cancer'20138,497,283'Autotaxin inhibitors'20138,329,907'Autotaxin inhibitors'20128,110,583'Tetrahydroquinoline derivatives'20128,097,727'N,N′-diphenylurea derivatives which are suitable as kinase inhibitors'20127,915,416'Tetrahydroquinolines'20117,696,224'Phenylurea derivatives as inhibitors of tyrosine kinases for the treatment of tumour diseases'20107,632,951'Inhibitors of integrin ανβ6 '20097,547,695'Pyridopyrimidinones'20097,528,139'Sulfonamides'20097,470,702'Benzimidazoles'20087,138,417'Inhibitors of integrin αvβ6'20067,135,587'Urea and urethane derivatives as integrin inhibitors'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2018Patents assigned to MERCK PATENT GMBH (33)· patent assignee history
2006–2018Based in Ingelheim am Rhein, DE· patent location history
2006Based in Seeheim-Jugenheim, DE· patent location history
2012–2016Patents assigned to STAEHLE WOLFGANG (16)· patent assignee history
2012–2016Patents assigned to SCHIEMANN KAI (11)· patent assignee history
2012–2015Patents assigned to SCHULTZ MELANIE (9)· patent assignee history
2013–2016Patents assigned to WIENKE DIRK (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK PATENT GMBH | 33 | 2006–2018 |
| STAEHLE WOLFGANGself | 16 | 2012–2016 |
| SCHIEMANN KAI | 11 | 2012–2016 |
| SCHULTZ MELANIE | 9 | 2012–2015 |
| WIENKE DIRK | 3 | 2013–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Ingelheim am Rhein, DE | 32 | 2006–2018 |
| Seeheim-Jugenheim, DE | 1 | 2006 |